Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors. - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

43016.1 IP-LS

Project title

Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.
Short description (English)	Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.
Abstract (German)	Cellestia Biotech is a clinical stage company based in Basel, Switzerland. The company is developing first-in-class innovative anti-cancer therapies by targeting undruggable transcription factors (TFs). The aim of the study is to expand pipeline by designing and developing novel anti-cancer agents.